These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16890841)

  • 1. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.
    Montaner JS; Hogg R; Wood E; Kerr T; Tyndall M; Levy AR; Harrigan PR
    Lancet; 2006 Aug; 368(9534):531-6. PubMed ID: 16890841
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV prevention and treatment in Africa.
    Laurence J
    AIDS Patient Care STDS; 2000 Aug; 14(8):399-400. PubMed ID: 10977967
    [No Abstract]   [Full Text] [Related]  

  • 3. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
    Lima VD; Johnston K; Hogg RS; Levy AR; Harrigan PR; Anema A; Montaner JS
    J Infect Dis; 2008 Jul; 198(1):59-67. PubMed ID: 18498241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global situation of the HIV/AIDS pandemic, end 2003. Part II: Estimating ARV global treatment needs (2003-2005).
    Wkly Epidemiol Rec; 2003 Dec; 78(50):426-30. PubMed ID: 14702672
    [No Abstract]   [Full Text] [Related]  

  • 5. Balancing effectiveness and access to HIV treatment in the developing world.
    Hill A; Wood E
    AIDS; 2007 Jan; 21(3):361-3. PubMed ID: 17255743
    [No Abstract]   [Full Text] [Related]  

  • 6. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.
    Long L; Fox M; Sanne I; Rosen S
    AIDS; 2010 Mar; 24(6):915-9. PubMed ID: 20042849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is antiretroviral therapy cost-effective in South Africa?
    Braithwaite RS; Tsevat J
    PLoS Med; 2006 Jan; 3(1):e60. PubMed ID: 16435892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
    Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
    AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS prevention more cost-effective than HAART treatment.
    AIDS Policy Law; 2002 Jun; 17(11):2. PubMed ID: 12083037
    [No Abstract]   [Full Text] [Related]  

  • 10. Providing antiretroviral therapy for HIV infection.
    Steinbrook R
    N Engl J Med; 2001 Mar; 344(11):844-6. PubMed ID: 11248164
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral therapy in children--increased benefit from increased complexity.
    Cotton MF
    S Afr Med J; 2000 Oct; 90(10):985-8. PubMed ID: 11081099
    [No Abstract]   [Full Text] [Related]  

  • 12. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [5th French-speaking conference on HIV/AIDS (Casablanca, 28-31 March 2010)].
    Milleliri JM; Goudjo A
    Med Trop (Mars); 2010 Jun; 70(3):226-8. PubMed ID: 20734588
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.
    Long EF; Brandeau ML; Galvin CM; Vinichenko T; Tole SP; Schwartz A; Sanders GD; Owens DK
    AIDS; 2006 Nov; 20(17):2207-15. PubMed ID: 17086061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/AIDS.
    Saag MS; Masur H
    Infect Dis Clin North Am; 2014 Sep; 28(3):xv-xvi. PubMed ID: 25151570
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
    Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
    N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARV compliance--the new battle terrain.
    Bateman C
    S Afr Med J; 2004 Aug; 94(8):602-3, 605. PubMed ID: 15352575
    [No Abstract]   [Full Text] [Related]  

  • 18. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).
    Gazzard B;
    HIV Med; 2005 Jul; 6 Suppl 2():1-61. PubMed ID: 16011536
    [No Abstract]   [Full Text] [Related]  

  • 19. An economic case for providing free access to antiretroviral therapy for HIV-positive people in South Australia.
    Heymer KJ; Wentzlaff-Eggebert M; Mortimer E; Wilson DP
    Sex Health; 2012 Jul; 9(3):220-6. PubMed ID: 22697138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
    Badri M; Cleary S; Maartens G; Pitt J; Bekker LG; Orrell C; Wood R
    Antivir Ther; 2006; 11(1):63-72. PubMed ID: 16518961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.